Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Medica Group PLC - Hastings, England-based provider of services such as x-ray and MRI scan analysis to hospitals - Notes failure to re-tender for a new diabetic retinopathy screening contract in Ireland. Says it is evaluating its response, but expects time needed for services to transition to a new provider. Anticipates no material adverse impact on its revenue and profit in 2023. Notes it does not have to pay €1.6 million to the sellers of Medica Ireland, formerly Global Diagnostics Ireland. Further, reports ‘strong growth’ in its core radiology services business line in 2022 as well as outperformance of its own year-to-date revenue expectations across its scanning and reporting services. For 2023, the company says it remains ‘well-positioned for growth’.
Current stock price: 211.25 pence, up 0.1% on Friday
12-month change: up 36%
Copyright 2023 Alliance News Ltd. All Rights Reserved.